Not mine, they’re making up for what this one lacks. It would be a real shame to go through this OTC season and have this sitting here. Do they have any foresight at all? Have they weighed whether or not it’s worth what they’re doing to shareholders etc? I kinda see a “screw the shareholder mentality” since they “don’t pay attention to share price” since they don’t rely on it for paying the bills. Message received, y’all don’t give a shit and at the end of the day you might be a good Co but a crappy reputation and people pumping this and getting indicted is not a good look. And stick the elephant although I’m thinking now quite appropriate.
News 
Market Data 
Discover 
